SuspendedNCT05924594
Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301
Medication studyAges 6–12United States
Understand this study
Who could participate?
Listed age limits: 6 years to 12 years.
- Listed locations
- Maitland and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 31, 2023
- Recruitment status
- Suspended
- Enrollment listed in the registry
- 45
- Sponsor
- Cingulate Therapeutics
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT05924594
- Official title
Show the full official title
A Phase 3, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy and Safety Laboratory Classroom Study in Children (6-12) With Attention-Deficit/Hyperactivity Disorder (ADHD) Using CTx-1301 (Dexmethylphenidate)
Recruitment & locations
SuspendedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Maitland · Las Vegas · North Charleston
Questions about this study
Who is behind this study?
The study sponsor is Cingulate Therapeutics.
Does this study involve medication?
Yes. The study involves medication, including CTx-1301 - Dexmethylphenidate 6.25mg, CTx-1301 - Dexmethylphenidate 12.5mg, CTx-1301 - Dexmethylphenidate 18.75mg, CTx-1301 - Dexmethylphenidate 25.0mg, CTx-1301 - Dexmethylphenidate 31.25mg, CTx-1301 - Dexmethylphenidate 37.5mg and Placebo.
Who can participate?
Listed age limits: 6 years to 12 years.
Is this study still recruiting?
The registry lists this study as suspended.
